Roberto A. Mignone's Insider Trades & SAST Disclosures
Roberto A. Mignone's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 286,000 Ordinary Shares done at an average price of $22.0 . Disclosure was reported to the exchange on Dec. 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Roberto A. Mignone.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- Pharmaceutical Indus... | A. Roberto Mignone | Director | Sale of securities on an exchange or to another person at price $ 22.01 per share. | 20 Dec 2024 | 286,000 | 695,000 (0%) | 0% | 22.0 | 6,294,031 | Ordinary Shares |
| Guardant Health Inc | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 19,535 | 19,535 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 12,671 | 12,671 | - | - | Restricted Stock Units | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 18 Jun 2024 | 519,000 | 981,000 (0%) | 0% | 17.0 | 8,838,570 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 1,595,683 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 9,632 | 9,632 | - | - | Restricted Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges